title: Plerixafor-moblized stem cells alone are capable of inducing early engraftment across the MHC-haploidentical canine barrier.
authors.forename: Monica S
authors.initials: MS
authors.lastname: Thakar
authors.forename: Erlinda B
authors.initials: EB
authors.lastname: Santos
authors.forename: Simon
authors.initials: S
authors.lastname: Fricker
authors.forename: Gary
authors.initials: G
authors.lastname: Bridger
authors.forename: Rainer
authors.initials: R
authors.lastname: Storb
authors.forename: Brenda M
authors.initials: BM
authors.lastname: Sandmaier
mesh_terms: D000818:Animals; D019380:Anti-HIV Agents / Q000494:pharmacology; D001596:Benzylamines; D000080027:Cyclams; D004285:Dogs; D006239:Haplotypes; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006571:Heterocyclic Compounds / Q000494:pharmacology*; D015395:Histocompatibility Antigens Class I / Q000235:genetics* / Q000276:immunology
chemical_list: D019380:Anti-HIV Agents; D001596:Benzylamines; D000080027:Cyclams; D006571:Heterocyclic Compounds; D015395:Histocompatibility Antigens Class I; C039692:histocompatibility antigen DLA; C088327:plerixafor